Coleman Mark's Form 4 filing
Axsome Therapeutics, Inc.AXSM · filed May 20, 2025
- Accession no.
- 0000950170-25-075539
- Filed
- May 20, 2025
- Trade date
- May 20, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $322.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman MarkCIK 0001658379 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Common Stock | SSaleDisposed | −3,000 | $107.49F2 | −$322,470 | 54,137 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $107.34 and $107.65.
Referenced by the price of 1 transaction in Table I.